Cassandra Hemby, APRN
Nurse Practitioner · Winter Haven, FLNPI 1235910647
Payments from drug & device makers
Across 266 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$791
- Johnson & Johnson$730
- UCB, Inc.$583
- E.r. Squibb & Sons, L.L.C.$416
- Pfizer$377
- AstraZeneca$315
- plus $2K from 36 others
What the payments were for
- Food & beverage$4,76492%
- Education$3998%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $791 |
| Johnson & Johnson | 40 | $730 |
| UCB, Inc. | 38 | $583 |
| E.r. Squibb & Sons, L.L.C. | 21 | $416 |
| Pfizer | 15 | $377 |
| AstraZeneca(2 entities) | 13 | $315 |
| Amgen | 19 | $281 |
| Mallinckrodt Hospital Products Inc. | 10 | $160 |
| GSK | 9 | $141 |
| Novartis | 6 | $114 |
| Lilly USA, LLC | 5 | $100 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Sanofi | 3 | $99 |
| Fresenius Kabi USA, LLC | 4 | $78 |
| Genentech USA, Inc. | 4 | $75 |
| Radius Health, Inc. | 4 | $73 |
| Sobi, Inc | 3 | $66 |
| Aurinia Pharma U.S., Inc. | 3 | $65 |
| Boehringer Ingelheim | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Deciphera Pharmaceuticals Inc. | 2 | $39 |
| Merck | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $36 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Bristol Myers Squibb | 1 | $26 |
| Incyte Corporation | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Tersera Therapeutics LLC | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Gilead | 1 | $21 |
| Bayer | 1 | $21 |
| Exelixis Inc. | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $17 |
| LEO Pharma Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $15 |
How this compares
$5,163 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 44 | $1,188 |
| Leflunomide | 12 | $561 |
| Methylprednisolone | 66 | $450 |
| Gabapentin | 13 | $390 |
| MethotrexateMethotrexate Sodium | 11 | $173 |
| Prednisone | 20 | $155 |
| Cyclobenzaprine Hcl | 15 | $146 |
| Meloxicam | 32 | $53 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Winter Haven
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.